Siponimod for the treatment of secondary progressive multiple sclerosis.
Dumitrescu Laura, Constantinescu Cris S, Tanasescu Radu·Expert opinion on pharmacotherapy
Multiple sclerosis (MS) is a chronic central nervous system immune-mediated disease with an important inflammatory component associated with focal demyelination and widespread neurodegeneration. In most cases, the clinical presentation is relapsing-remitting, followed by a secondary progressive phase, characterized by…